A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally
Condition:   Recurrent Herpes Labialis Interventions:   Drug: Acyclovir 50mg buccal tablet, BAYM008894/UI1614773;   Drug: Placebo Sponsor:   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2021 Category: Research Source Type: clinical trials

Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject
Condition:   Drug Use Interventions:   Drug: Acyclovir 200 MG;   Drug: Acyclovir 400 MG;   Drug: Zovirax 200 MG Tablet;   Drug: Zovirax 400 MG Tablet Sponsors:   PT. Kimia Farma (Persero) Tbk;   PT Pharma Metric Labs Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2021 Category: Research Source Type: clinical trials